Plasmodial Kinase Inhibitors Targeting Malaria: Recent Developments

Recent progress in reducing malaria cases and ensuing deaths is threatened by factors like mutations that induce resistance to artemisinin derivatives. Multiple drugs are currently in clinical trials for malaria treatment, including some with novel mechanisms of action. One of these, MMV390048, is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mustière, Romain, Vanelle, Patrice, Primas, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765515/
https://www.ncbi.nlm.nih.gov/pubmed/33334080
http://dx.doi.org/10.3390/molecules25245949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765515/
https://www.ncbi.nlm.nih.gov/pubmed/33334080
http://dx.doi.org/10.3390/molecules25245949

Ejemplares similares